These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 26884479

  • 1. Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome.
    Rissanen AP, Koskela-Koivisto T, Hägglund H, Koponen AS, Aho JM, Pöyhönen-Alho M, Tiitinen A, Tikkanen HO, Peltonen JE.
    Physiol Rep; 2016 Feb; 4(4):. PubMed ID: 26884479
    [Abstract] [Full Text] [Related]

  • 2. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D, Harrison CL, Hutchison S, de Courten B, Stepto NK.
    PLoS One; 2017 Feb; 12(8):e0182412. PubMed ID: 28771628
    [Abstract] [Full Text] [Related]

  • 3. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL, Stepto NK, Hutchison SK, Teede HJ.
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [Abstract] [Full Text] [Related]

  • 4. Serum testosterone predicts cardiorespiratory fitness impairment in normal-weight women with polycystic ovary syndrome.
    Bacchi E, Negri C, Di Sarra D, Tosi F, Tarperi C, Moretta R, Schena F, Bonora E, Kaufman JM, Moghetti P.
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):895-901. PubMed ID: 26173542
    [Abstract] [Full Text] [Related]

  • 5. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [Abstract] [Full Text] [Related]

  • 6. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M, Duran C, Guney I, Elmas H, Ayhan M, Erdem SS.
    Clin Investig Arterioscler; 2020 Jan; 32(6):256-262. PubMed ID: 32773256
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C, McGrath BP, Teede HJ.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [Abstract] [Full Text] [Related]

  • 12. Cardiac output and arteriovenous oxygen difference contribute to lower peak oxygen uptake in patients with fibromyalgia.
    Lehto T, Zetterman T, Markkula R, Arokoski J, Tikkanen H, Kalso E, Peltonen JE.
    BMC Musculoskelet Disord; 2023 Jul 01; 24(1):541. PubMed ID: 37393269
    [Abstract] [Full Text] [Related]

  • 13. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
    Ollila MM, West S, Keinänen-Kiukaanniemi S, Jokelainen J, Auvinen J, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Franks S, Piltonen TT, Morin-Papunen LC.
    Hum Reprod; 2017 Feb 01; 32(2):423-431. PubMed ID: 28031324
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.
    Alebić MŠ, Bulum T, Stojanović N, Duvnjak L.
    Endocrine; 2014 Nov 01; 47(2):625-30. PubMed ID: 24522614
    [Abstract] [Full Text] [Related]

  • 16. Central and peripheral cardiovascular impairments limit VO(2peak) in type 1 diabetes.
    Rissanen AP, Tikkanen HO, Koponen AS, Aho JM, Peltonen JE.
    Med Sci Sports Exerc; 2015 Feb 01; 47(2):223-30. PubMed ID: 24983341
    [Abstract] [Full Text] [Related]

  • 17. Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome.
    Giallauria F, Palomba S, Manguso F, Vitelli A, Maresca L, Tafuri D, Lombardi G, Colao A, Vigorito C, Orio F.
    Clin Endocrinol (Oxf); 2008 Jan 01; 68(1):88-93. PubMed ID: 17803701
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Panidis D.
    Gynecol Endocrinol; 2013 Mar 01; 29(3):250-3. PubMed ID: 23216335
    [Abstract] [Full Text] [Related]

  • 19. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U, Pall M, Mathur R, Azziz R.
    Hum Reprod; 2014 Jul 01; 29(7):1508-17. PubMed ID: 24813197
    [Abstract] [Full Text] [Related]

  • 20. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD, Noakes M, Moran LJ, Norman R, Clifton PM.
    BJOG; 2006 Nov 01; 113(11):1308-14. PubMed ID: 17059392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.